EX-21.1 6 fy16ex211subsidiaries.htm EXHIBIT 21.1 Exhibit


SUBSIDIARIES OF THE COMPANY

 
 
 
 
 
Name of Subsidiary
 
Jurisdiction
 
Doing Business As
 
Advanced Liquid Logic Inc.
 
Delaware
 
Advanced Liquid Logic Inc.
BlueGnome, Ltd.
 
United Kingdom
 
BlueGnome, Ltd.
Epicentre Technologies Corporation
 
Wisconsin
 
Epicentre Biotechnologies
GenoLogics Life Science Software Inc.
 
Canada
 
GenoLogics Life Science Software Inc.
Illumina Australia Pty. Ltd.
 
Australia
 
Illumina Australia Pty. Ltd.
Illumina Brasil Produtos de Biotecnologia Ltda.
 
Brazil
 
Illumina Brazil
Illumina Cambridge, Ltd.
 
United Kingdom
 
Illumina Cambridge, Ltd.
Illumina Canada, Inc.
 
Canada
 
Illumina Canada, Inc.
Illumina France Holding Sarl
 
France
 
Illumina France Holding Sarl
Illumina France Sarl
 
France
 
Illumina France Sarl
Illumina GmbH
 
Germany
 
Illumina GmbH
Illumina Hong Kong Limited
 
Hong Kong
 
Illumina Hong Kong Limited
Illumina Iceland ehf
 
Iceland
 
Illumina Iceland ehf
Illumina Italy S.r.l.
 
Italy
 
Illumina Italy S.r.l.
Illumina K.K. Japan
 
Japan
 
Illumina K.K. Japan
Illumina Netherlands B.V.
 
Netherlands
 
Illumina Netherlands B.V.
Illumina New Zealand Limited
 
New Zealand
 
Illumina New Zealand Limited
Illumina Singapore Pte. Ltd.
 
Singapore
 
Illumina Singapore Pte. Ltd
Illumina Trading (Shanghai) Co., Ltd.
 
China
 
Illumina Trading (Shanghai) Co., Ltd.
Illumina Switzerland GmbH
 
Switzerland
 
Illumina Switzerland GmbH
Illumina Europe Limited
 
United Kingdom
 
Illumina Europe Limited
Illumina Denmark ApS
 
Denmark
 
Illumina Denmark ApS
Illumina Productos de Espana, S.L.U.
 
Spain
 
Illumina Productos de Espana, S.L.U.
Illumina AB
 
Sweden
 
Illumina AB
NextBio
 
California
 
NextBio
Verinata Health, Inc.
 
Delaware
 
Verinata Health, Inc.
**All listed subsidiaries are wholly-owned, direct or indirect, subsidiaries of Illumina, Inc.

**As permitted under Rule 601 of Regulation S-K, we have omitted the names of subsidiaries, which if considered in the aggregate as a single subsidiary, would not constitute a “significant subsidiary” (as defined in Rule 1-02(w) of Regulation S-X) as of the end of the year covered by this report